Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kinesin-like protein KIF11 (Eg5) is a motor protein essential for mitosis in human cells. It establishes bipolar spindle formation during cell division by cross-linking anti-parallel microtubules. Inhibition or loss of function leads to monopolar spindles and cell cycle arrest at mitosis, making it an active anticancer drug target. Small-molecule inhibitors like GSK‑1 trap Eg5 on the microtubule lattice, blocking its function.
Inhibition of KIF11 traps Eg5 on the microtubule lattice, stabilizing an "ATP-like" conformation without nucleotide bound, blocking its function allosterically, leading to failed bipolar spindle formation and cell cycle arrest.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kinesin-like protein KIF11 (Eg5).